On the afternoon of November 6, the Hunan Golden Hibiscus Fund Sci-Tech Innovation Ecosystem Alliance held a grand ceremony at Changsha Xiangjiang Fortune Financial Center to launch its technology transfer program and inaugurate the dedicated board for technology commercialization on the regional equity market. Shen Fanshun, Party Branch Secretary and Chairman of the company, attended the event and officially struck the gong to mark the launch of the Hunan Equity Exchange's technology transfer board.

The Technology Transfer Board is designed to implement the guiding principles from the Fourth Plenary Session of the 20th CPC Central Committee, which emphasized "accelerating high-level technological self-reliance and strength" and "deepening the integration of scientific innovation with industrial innovation." It aims to rapidly cultivate new productive forces, establish a new frontier for technological innovation, and facilitate the transition of Hunan Province's multi-tiered capital market services from "laboratories" to "production lines" for scientific achievements. Positioned as an "incubation hub" and "accelerator" for technology transfer in the province, it serves early-stage enterprises with significant potential and demand for technology commercialization. Through model innovation, resource integration, and institutional reforms, the board seeks to build and refine a comprehensive "full-chain" service system for technology transfer, enabling a batch of scientific achievements to be effectively commercialized and implemented.

As the industrialization base for Hunan University of Chinese Medicine and Hunan Academy of Chinese Medicine's research achievements in ultrafine traditional Chinese medicine technology, the company is recognized as a high-tech enterprise in Hunan Province, a key listed reserve enterprise, a top 100 strategic emerging industry enterprise, and a "specialized, refined, unique, and innovative" (SRI) small giant enterprise. Its ultrafine traditional Chinese medicine technology has won the First Prize of Hunan Provincial Science and Technology Progress Award and the Second Prize of National Science and Technology Progress Award, pioneering the completion of a gap in Hunan's traditional Chinese medicine sector's national science and technology progress awards. This time, the company has been listed on the Hunan Stock Exchange's Technology Transfer Board (Stock Code: 320001HN) as the first enterprise, reflecting the market and authoritative institutions 'high recognition of its comprehensive strength and development potential, and demonstrating Hunan Province's strong expectations for the modern traditional Chinese medicine industry.

"While our technology has won a national award, there remains significant room for further research, which will require substantial funding," stated Shen Fanshun, Chairman of the company. Listing on the Sci-Tech Achievements Transformation Board of the Stock Exchange will open up additional financing channels to support future R&D. Moreover, the company is currently developing a series of new products under the 'food-as-medicine' concept, aiming to integrate more resources and talent to guide and explore new market demands.

The company will take this listing on the special board as an opportunity to further increase R&D investment, improve industrial layout, and accelerate market expansion under the empowerment and support of the capital market. It will launch a series of scientific research and innovation achievements, including food-and-drug-derived health products, new traditional Chinese medicine decoctions, and classic traditional Chinese medicine preparations, contributing wisdom and strength to the health of China.